Status:
COMPLETED
Uric Acid Levels and Migraine in Children
Lead Sponsor:
Aysen Orman
Conditions:
Migraine in Children
Eligibility:
All Genders
6-18 years
Brief Summary
Migraine is recognized as one of the most prevalent neurological disorders. The exact pathophysiological mechanisms underlying migraine have not yet been fully elucidated. The present study aims to co...
Detailed Description
Migraine is recognized as one of the most prevalent neurological disorders. The exact pathophysiological mechanisms underlying migraine have not yet been fully elucidated. The present study aims to co...
Eligibility Criteria
Inclusion
- Patients diagnosed with migraine
Exclusion
- Cerebral palsy Non-migraine headache Epilepsy Multiple congenital anomalies Congenital metabolic diseases Control group
- Inclusion Criteria:
- Healthy children Exclusion Criteria Neuromotor developmental delay Multiple congenital anomalies Non-migraine headache Epilepsy
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT06966037
Start Date
August 1 2019
End Date
April 1 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mersin University
Mersin, Turkey (Türkiye), 33000